|
BD KOREA |
Marketing Specialist(PreAnalytical Systems)
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
3³â¡è |
ä¿ë½Ã |
03.08 |
|
|
¾ÆÀÌÁø |
»ç¾÷°³¹ß(BD) ¹× °øÁ¤°³¹ßÆÀ ¿¬±¸¿ø ä¿ë
°æ±â °í¾ç½Ã ´ö¾ç±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
°æ·Â¹«°ü |
ä¿ë½Ã |
09.27 |
|
|
(ÁÖ)¼¿ïÁ¦¾à |
Ç°Áú°ü¸® °æ·Âä¿ë
ÃæºÏ ûÁֽà Èï´ö±¸ | Çз¹«°ü |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
°æ·Â¹«°ü |
ä¿ë½Ã |
02.26 |
|
|
(ÁÖ)¿øÄÄÆÛ´Ï |
¹°·ùÁ÷¿ø ¸ðÁý
¼¿ï ÀüÁö¿ª | Çз¹«°ü |
°ø°³Ã¤¿ë |
°æ·Â¹«°ü |
ä¿ë½Ã |
05.10 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Business Insight & Analytics specialist
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°æ¿µ/Àü·«±âȹ/ÄÁ¼³Æà |
5³â¡è |
ä¿ë½Ã |
08.06 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] New Product Brand Lead
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
5³â¡è |
ä¿ë½Ã |
08.06 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Insulin Junior Product Manager
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
3³â¡è |
ä¿ë½Ã |
08.06 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Diabetes Medical Lead
¼¿ï ¼Ãʱ¸ | ´ëÇпø(¼®»ç) Á¹¾÷ |
˂ȍ |
°æ·Â¹«°ü |
ä¿ë½Ã |
08.20 |
|
|
Á¦ÀϾàÇ°(ÁÖ) |
Á¦ÀϾàÇ° [»ý»ê, Ç°Áúº¸Áõ, Ç°Áú°ü¸®] °æ·ÂÁ÷ ä¿ë
°æ±â ¿ëÀνà | Çз¹«°ü |
»ý»ê/»ý»ê°ü¸® |
°æ·Â¹«°ü |
ä¿ë½Ã |
10.08 |
|
|
´õºíÀ¯¸ÞµðÄ®(W-medical) |
ÀÇ·á±â±â Á¦Á¶, Á¦Ç°°³¹ß, ÀÚÀç°ü¸® Á¤±ÔÁ÷ ä¿ë(½ÅÀÔ&°æ·Â)
°æ±â ³²¾çÁֽà | °íµîÇб³ |
»ý»ê/»ý»ê°ü¸® |
°æ·Â¹«°ü |
ä¿ë½Ã |
02.21 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Field medical, Dupilumab (Medical manage
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
10³â¡è |
ä¿ë½Ã |
10.28 |
|
|
(ÁÖ)¼¼Æ÷¹ÙÀÌ¿À |
[±â¾÷ºÎ¼³¿¬±¸¼Ò] ¸é¿ªÄ¡·áÁ¦ °³¹ß ¿¬±¸¿ø ä¿ë ¸ðÁýÁß
¼¿ï Á¾·Î±¸ | ´ëÇпø(¼®»ç) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
°æ·Â¹«°ü |
ä¿ë½Ã |
10.15 |
|
|
ÁÖ½Äȸ»ç ÆÄÀÎÀÌ¿¥ÅØ |
ÁÖ½Äȸ»ç ÆÄÀÎÀÌ¿¥ÅØ ¿ÏÁ¦ÀǾàÇ° ÀÎÇã°¡ ¹× »ý»êÀοø¸ðÁý
°æ±â ±¤¸í½Ã | °íµîÇб³ |
°ø°³Ã¤¿ë |
°æ·Â¹«°ü |
ä¿ë½Ã |
06.20 |
|
|
Çѱ¹MSD À¯ÇÑȸ»ç |
RA Specialist ä¿ë
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
1³â¡è |
ä¿ë½Ã |
06.20 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] (Sr.) Product Manager
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
5³â¡è |
ä¿ë½Ã |
08.06 |
|